Author | Audrey Sternberg


CLL Treatment Further Refined With Venetoclax Data Updates

October 27, 2020

The introduction of venetoclax into the treatment paradigm of chronic lymphocytic leukemia has led to options for time-limited therapy in a space that has been dominated by continuous therapeutic agents.

Expert Reviews Novel Strategies in the Pipeline for the Treatment of ER-Positive Breast Cancer

October 22, 2020

Recent acceleration in the introduction of new regimens for the treatment of estrogen receptor–positive breast cancer has led to significant survival enhancement, but questions remain regarding how patients should be stratified following disease progression with these therapies.

Targeted Agents Induce Significant Efficacy in Older, Frail Patients With ALL

October 17, 2020

On the treatment of adult patients with acute lymphoblastic leukemia, long-term cure rates in elderly populations, or those older than 55 to 60 years of age, are approximately 15% to 20% and represent a clinically unmet need in this hematologic cancer.

Management of Early Stage Hodgkin Lymphoma Requires “Balancing” Individual Risk

October 10, 2020

When choosing therapy for patients with early stage Hodgkin lymphoma, considering risk scoring systems and Deauville criteria for PET-adapted therapy are key conditions for optimizing survival rates, according to Ranjana H. Advani, MD.